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ABSTRACT: A continuous manufacturing process for pharmaceutical indometha-
cin−saccharine cocrystals was achieved by extrusion processing with high throughput.
Down-stream milling and blending of the extrudates was followed by feeding the formu-
lated cocrystals in a capsule-ﬁlling machine. By applying a quality by design approach,
the process was optimized and scaled up to produce 3000 capsules/h of pharmaceutical
cocrystals. Process analytical tools such as near infrared reﬂectance and spatial ﬁlter
velocimetry probes were coupled at various process stages for in-line monitoring and
quality control. Further physicochemical characterization of extruded batches conﬁrmed
the manufacturing of high quality cocrystals. A fully integrated continuous process
starting from raw materials to produce a ﬁnished product was assembled with only
six unit operations and a small footprint. The study is a paradigm of continuous
manufacturing of pharmaceutical cocrystals.
■ INTRODUCTION
Pharmaceutical industries are facing enormous challenges in their
quest to satisfy regulatory constraints, ﬂexible market demands,
operational complexities, and economic limitations.1−4 Market
globalization has considerably decreased the patent lifetime of
new-ﬁnished drug products. This has forced manufacturers to
minimize the development time associated with new drugs as well
as maximize their throughput. To date most pharmaceutical
processes involve conventional manufacturing approaches, such as
batch production. However, batch based manufacturing presents
several disadvantages such as deﬁned batch size, multiple sequen-
tial steps, interruptions, long waiting and throughput times, raw
material waste, extensive validation, and scale up activities
compared to continuous processes.1 Because of the foregoing
market needs and drawbacks associated with batchmanufacturing,
regulatory bodies are encouraging the development and imple-
mentation of innovative pharmaceutical processes such as
continuous manufacturing. Continuous manufacturing (CM) is
well accepted in other industries such as food, paper, plastic, and
ceramic, while it is now being gradually accepted in the pharma-
ceutical industry. Among the several advantages of CM is the
increased eﬃciency of equipment use, savings in energy con-
sumption, reduction of scrap/waste, lower costs, safety, and less
complex scale-up, butmost importantlyfully automated
ﬁnished product manufacturing and the reduced time to market
(throughput manufacturing time). One of the biggest challenges
facing the pharmaceutical industry in moving forward is to identify
model CM platforms and, consequently, deal with the “how” or
technical issues involved in their implementation. Various
approaches have been reported for continuous manufacturing
such as roller compaction and twin-screw granulation,5,6 but only a
few have resulted in complete multiunit processes.7−9 A complete
end-to-end process which involves synthesis, puriﬁcation, and for-
mulation of a ﬁnal dosage form has been reported by Mascia et al.
for the manufacturing of aliskiren hemifumarate tablets. Pharma-
ceutical cocrystals have attracted signiﬁcant interest in the past few
years due to their potential to modify the physicochemical prop-
erties of a drug substance such as stability, solubility, and bio-
availability. The development of a new solid form of a drug
substance by altering the crystal packing through drug−conformer
supramolecular interactions has led to the formation of various
cocrystals products.10−14 Herein, we introduce a secondary
continuous cocrystallization manufacturing process by means of
hot melt extrusion (HME) with in-line integrated process
analytical tools for process monitoring and quality control.
Although HME has been previously used for the formation of
pharmaceutical cocrystals,15−20 this is the ﬁrst report of a fully
scalable, continuous HME process coupled with PAT probes21
resulting in a ﬁnal dosage form.
■ MATERIALS AND METHODS
Materials. Indomethacin (γ-form, IND, >98.0%) and saccharin
(SCH, >99.0%) were purchased from Tokyo Chemicals (Tokyo, Japan)
and Sigma-Aldrich Company Ltd. (Dorset, UK), respectively, and used
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as received. All solvent used for HPLC analysis were of analytical grade
(Fisher Chemical, UK).
Description of Continuous Processing. Equimolar amounts
(1:1) of IND and SCH were accurately weighed and homogeneously
blended for 10 min using a Turbula mixer. The prepared blended
powder was fed into a twin-screw extruder (Eurolab 16, Thermo Fisher,
Germany) via a DD Flexwall 18 feeder (Brabender Technology,
Germany). Table 1 shows the settings for the processing parameters
such as the temperature proﬁles, screw speed, and feed rate used for the
optimization of the synthesis of the cocrystals via HME. The twin-screw
extruder was operated without a die, and the extruded cocrystals were
collected in powder form.
The as-synthesized cocrystals were fed into a cutter mill (CuttingMill
SM 100, Retsch, UK) for further particle size reduction using a constant
rotating speed of 1500 rpm. For the purposes of the size reduction, a
250 μM sieve was placed at the bottom of the casing holds of the cutter
mill in order to process the cocrystals discharged at the end of the
extrusion process. A convective twin-screw blender was also placed
underneath the cutter mill in order to process the micronized cocrystals.
The role of the blender was to provide continuous, homogeneous,
and uniform powder blending. The powder ﬂow was axial by varying the
impeller rotation (34 blades), while the processing angle was kept
constant (0° angle). A second gravimetric feeder (K-tron T35, Coperion,
Stockport, UK) was calibrated to supply the bulking excipients at various
feed rates during process optimization and scale-up (0.3−3.75 kg/h).
The blended powders were fed directly from the outlet of the conveyor
into the hopper of the Mini-Cap capsule ﬁller (Karnavati Engineering
Ltd., India).
Oﬀ-Line Physicochemical Characterization. Diﬀerential scan-
ning calorimetry (DSC) analysis was carried out by using a Mettler-
Toledo 823e instrument (Greifensee, Switzerland). The accurately
weighed samples were crimped in 40 μm aluminum pans and heated
from 25 to 250 °C at a scan rate of 10 °C/min using nitrogen as a purge
gas at a ﬂow rate of 50 mL/min. STARe excellence software provided
with the instrument software was used for further data analysis.
X-ray powder diﬀraction (XRPD) was used to determine the solid
state of bulk materials, physical mixtures, and hot-melt extrudates using a
Bruker D8 Advance (Germany) instrument in theta−theta mode. A Cu
anode at 40 kV and 40 Ma, parallel beam Goebel mirror, 0.2 mm exit
slit, LynxEye Position Sensitive detector with 3° opening (LynxIris at
6.5 mm) and sample rotation of 15 rpm were used. Each sample was
scanned from 2 to 40° 2θwith a step size of 0.02° 2θ and a counting time
of 0.3 s per step. Rietveld reﬁnements were performed using TOPAS
V4.2 (Bruker), and crystal structures were retrieved from the Cambridge
Structural Database.
The morphology of bulk IND, SCH, and the extruded cocrystals was
examined by scanning electron microscopy (Hitachi SU8030, Japan).
Samples were placed on a thin layer of Mikrostik nonconductive
adhesive (Agar scientiﬁc, UK) on an aluminum stub and coated with
chromium under an atmosphere of argon at room temperature.
Scanning electron microscopy (SEM) images were obtained by using
an electron beam accelerating voltage of 2 kV.
Dissolution studies were conducted by using a USP II paddle
apparatus (Varian 705, US). The amount of extruded powders was
equivalent to 25 mg of IND, placed into 900 mL of phosphate buﬀer
solution (pH 6.8), in each dissolution vessel (n = 3). The temperature of
the dissolution media was maintained at 37 °C with a paddle rotation
of 100 rpm. Samples, about 2−3 mL, were withdrawn at 15, 30, 60, and
120 min intervals and ﬁltered with a 200 μm ﬁlter prior to HPLC
analysis.
The content of IND in all the samples was conﬁrmed by HPLC.
The experiments were performed on an HPLC system (Agilent
Technologies, 1200 series) equipped with a quaternary pump.
A Hichrom S50DS2-4889 (5 μm × 150 mm × 4 mm) column was
employed. Column temperature and retention time were set at 25 °C
and 4 min, respectively. The mobile phase used was 70:30:0.2 (v/v/v)
methanol/water/acetic acid. The sample volume was 20 μL, injected by
using an auto sampler, the ﬂow rate used was 1.5 mL/min, and the
detector was set at a wavelength of 260 nm. The calibration curve for
IND was plotted over a concentration range of 10−50 μg/mL.
Oﬀ-line particle size analysis of the extruded cocrystals was conducted
by using a dry powder dispersion unit (Scirocco 2000) of a Mastersizer
2000 (Malvern, Worcestershire, UK) laser diﬀraction particle size
analyzer. Postextruded samples were placed in a vibratory tray, which
continuously controls the rate of powder ﬂow, in order to measure the
particle size oﬀ-line. Three particle size measurements were obtained, in
continuous sequence, in order to assess the reproducibility of each batch
of extrudates. The Mastersizer 2000 software automatically displayed
particle size distributions.
Fourier transform infrared (FT-IR) spectra were obtained using a
PerkinElmer spectrophotometer (Spectrum 100, PerkinElmer, US)
equipped with a crystal diamond universal ATR sampling accessory
(UATR). Solid samples were placed in contact with the universal
diamond ATR top-plate and an average spectrum of 64 scans was
recorded in the 4000−400 cm−1 wavenumber range.
In-Line Process Monitoring. Diﬀusion reﬂectance near infrared
(NIR) spectra were continuously collected in-line and noninvasively
during extrusion cocrystallization using Fourier-Transform Antaris MX
NIR analysers (Thermo Fisher Scientiﬁc, United Kingdom) supplied
with an InGAs detector, a quartz halogen lamp, and a ﬁber optic probe
placed at the end of the extruder. Spectra were recorded every 1 min in
the 10000−4000 cm−1 wavenumber region with a resolution of 16 cm−1
and averaged over 64 scans. A transmission probe was ﬁtted at the end of
the extruder, and the reﬂectance probe was inserted in the ﬁrst mixing
zone of the extruder barrel.
In-line particle size measurements were carried out by using a Parsum
probe (Parsum IPP70;Malvern, UK). Two particle size probes were used,
and the operational inlet and external pressures were set at 15 and
2 L/min, respectively. The ﬁrst probe was directly placed at the end of the
extruder and the secondwas placed underneath the 250mesh of the cutter
mill to measure the as-made and micronized cocrystals, respectively.
The particle size data were collected by using the IPP software provided
with the instrument. The scan rates used were 2−2.5 m/s (0.250 MHz,
free fall), 10−30 m/s (5 MHz, D23 in-line disperser). For the process
optimization, the D23 disperser attachments or the “free fall” mode
were used.
The probes are operated by compressed air to create a constant
curtain of scavenging air in front of the measurement optical system and
for the carriage and thinning of the particle jet. The compressed air
required is fed from an air regulation kit to the measurement chamber
inside the sensors and from there to the accessories (Figure S4).
The Parsum probe is based on the principle of spatial ﬁlter velocimetry,
and thus the size and velocity can be simultaneously extracted from
particles as they pass through a laser beam, casting shadows onto a linear
array of optical ﬁbers.
Table 1. Processing Parameter Settings Applied for the
Development and Scale-up of IND−SCH Cocrystals Using a
Constant Degree-of-Filla
temperature proﬁle (°C)
(feeder→ die)
screw rate
(rpm)
feeder rate
(kg/h)
residence
time (s) cocrystal
F1 50−70−95−130−140−
140−145−145−145
10 0.10 230.0 X
F2 70−95−145−150−155−
155−155−155−155
10 0.10 230.0 √
F3 70−95−145−150−155−
155−155−155−155
30 0.30 176.5 X
F4 50−70−95−155−160−
165−165−165−165
30 0.30 176.5 √
F5 50−70−95−155−160−
165−165−165−165
100 1.0 45.7 X
F6 70−95−155−165−175−
175−175−175−175
75 1.0 85.4 √
F7 70−95−155−165−175−
175−175−175−175
100 1.0 85.4 √
F8 70−95−155−165−175−
175−175−175−175
100 1.5 45.7 √
aEach batch was produced three times.
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Residence Time Distribution (RTD). Residence time distribution
was measured by using a modiﬁed approach similar to Ziegler et al.
(2002) corresponding to turning oﬀ the supply of an inert tracer.
The RTD is usually presented as the exit age distribution E(t) of a
material leaving the extruder. It is estimated as the response at the die
outlet to pulse tracer at t = 0 in some part of the extrusion barrel. In this
case the inert tracer was sodium ﬂuorescein-FlNa (Sigma-Aldrich, UK).
This is commonly referred to as a washout experiment (Nauman, 1985),
and for accurate determinations of residence time, the tracer should
not aﬀect the properties of the material being processed. Samples were
collected at the discharge end of the extruder at 10 s time intervals, and
the concentration of tracer wasmeasured using a Varian Cary 300 UV−Vis
spectrometer (Canada). The collected samples (5 mg) were dissolved in
distilled water, and the concentration of FlNa was measured at 475 nm.
Prior to the estimation of FlNa concentration, calibration curves were
plotted from 2−25 μg/mL.
■ RESULTS AND DISCUSSION
Figure 1 illustrates a schematic diagram of the HME process for
the formation of IND−SCH cocrystals with the capability to
operate for several days and produce 60 000 capsules/h
processed by using a 16 mm twin-screw extruder. The system
comprises only six unit operations with a footprint of 0.8× 3.5 m2.
The diagram also shows the PAT tools coupled at critical process
steps consisting of one NIR reﬂectance probe and two partial ﬁlter
velocimetry particle size probes.
The formation and quality optimization of IND−SCH
cocrystals was conducted in the absence of an extrusion die,
and the extrudates were collected in dry powder form. Studies
revealed that the temperature proﬁle, feed rate, and screw speed
were the three critical process parameters (CPP) required for the
engineering of high quality cocrystals. Screw conﬁguration is
another key parameter,22 but on this occasion we used a standard
screw conﬁguration provided by the instrument manufacturer.
Table 1 depicts the experimental plan that was designed in order
to identify the space control and process boundary for high quality
cocrystal manufacturing. The rationale of the experimental set in
Table 1 was to conduct scale-up of the formed corystals by
increasing initially the feed rate of the drug/conformer and
subsequently the screw speed and barrel temperature if
necessary. As shown, complete cocrystal formation was not
achieved when the initial extrusion temperature was set at 145 °C
with a screw speed of 10 rpm, as small traces of unreacted
material were detected by using DSC and XRPD analysis
(Supporting Information). Batches extruded at 155 °C, which is
the eutectic temperature of the IND−SCH physical blend,23
showed cocrystal formation and the absence of unreacted starting
materials. The eﬀect of screw speed and feed rate was further
investigated by increasing the rates to 30 rpm and 0.3 kg/h,
respectively, for the same temperature proﬁle.Higher screw speeds
facilitate the rapid transport of material through the extrusion
barrels of the hot-melt extruder with less residence time and this
parameter is directly related to the feeding rate.24 However,
higher feeding rates (at constant screw speed) can cause material
blockage in the extruder. An increase in the screw/feed rates
resulted, again, in incomplete cocrystal formation and the presence
of unreacted materials at maximum barrel temperatures of 155 °C.
Manufacturing of IND−SCH cocrystals at 30 rpm screw speed
required a further increase in extrusion temperature (165 °C).
Dhumal et al. (2010) reported that temperatures higher than the
eutectic point lead to material melting and facilitated mass transfer
due to additional degrees of freedom with enhanced molecular
collisions. Nevertheless, the obtained throughput of 0.3 kg/h is
considered low for a typical HME plant, and thus process scale-up
was optimized with a target of 1.0−1.5 kg/h. The screw speed was
increased proportionally to the feed rate in order to achieve a
constant degree-of-ﬁll for the fed drug and coformer. It is obvious
that when changes in extrusion screw speed and the feed rate are
made, the temperature proﬁle has to be optimized when using an
extruder of the same size. This is an interesting development, as
volumetric scale-up in plastic or polymer processing can usually
be achieved by altering only one process parameter at a time.25
The use of the high extrusion temperatures, above the drug-
coformer eutectic melting point, increases the possibility of drug
degradation and also limits the formation of cocrystals. However,
extrusion at 175 °C did not aﬀect IND and enabled the formation
of cocrystals. In addition, the residence time for extrusion was
signiﬁcantly reduced from 230 s to 45.7 s without having an eﬀect
on the resulting product quality. Figure 2 provides a schematic
representation of the process boundary and the melt temperature
dependence. As can be seen 175 °C is a critical processing temper-
ature as cocrystals are formed at feed: screw speed rates of
1.0 kg/h: 75 rpm and 1.5 kg/h: 100 rpm, respectively.
The RTD is a key tool with which to characterize the extrusion
cocrystallization process and it is aﬀected by the screw design/
conﬁguration and operating conditions.26,27 The RTD is usually
presented as the exit age distribution E(t) of a material leaving
the extruder. It is estimated as the response at the die outlet to
pulse tracer at t = 0 in some part of the extrusion barrel. The inset
in Figure 2 shows the RTD of the scaled-up batches (170 °C/
100 rpm) derived by using the following equations:
=
∑ Δ
E t
C t
C t t
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= ∑ Δ
∑ Δ
t
tC t t
C t t
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where C(t) is the tracer concentration,Δt is the sampling period,
and t is the sampling time.
The RTD was found to be 46.7 s with a time delay of 20 s and
then an increase to reach a maximumwithin 40−50 s followed by
Figure 1. Schematic diagram of CM processing by using a twin-screw
extruder, PAT tools, and downstream equipment for the formation of
pharmaceutical cocrystals.
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a relative rapid decrease.28,29 As expected, RTD reduced with an
increase in the screw speed.
The second goal of the study was to align the operation units
with HME for the production of gelatin capsules ﬁlled with
IND−SCH cocrystals. As Figure 1 shows, the extruded cocrystals
are fed into a cutter mill to reduce the particle size (downstream
equipment) and collected in a convective blender following
blending with other excipients from a second gravimetric
feeder30 calibrated and set at 0.45 kg/h. The blend of cocrystals
and excipients are subsequently fed into the hopper of an auto-
mated capsule-ﬁlling machine to produce hard gelatin capsules
(size 4) where each capsule contained the equivalent of 25 mg of
IND. Themilled cocrystals were blended with lactose, MCC, and
SiO2 at 40.0:31.5:28.3:0.2 wt/wt ratios. The blending rate of the
Figure 2. Schematic diagram of process boundary and scale-up (inset: RTD curve of scaled-up CM of IND−SCH cocrystals 100 rpm/175 °C (1.5 kg/h).
Figure 3. NIR second derivative reﬂectance spectra of bulk IND, SCH, PM, and in-line spectra of IND−SCH extruded cocrystals at various screw
speed/temperature conﬁgurations collected from the extrusion processing.
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twin-screw conveyor was set at 0.75 kg/h, while the capsule ﬁller
was programmed to follow a 10 min lag period prior to capsule
ﬁlling, in order to allow the transfer of enough material from the
conveyor to the capsule machine hopper. The process scale-up
allowed the production of IND−SCH capsules at a rate of 3000/h,
which was the maximum operating rate of the capsule-ﬁlling
device. The CM of the extruder and the downstream equipment
was allowed to operate successfully for 3 h.
Process monitoring and quality control were achieved by using
an in-line NIR probe at the end of the extruder and a particle size
probe placed underneath the cutter mill. The NIR probe is set to
monitor the “as made” IND−SCH cocrystals, while the spatial
velocimetry particle probe is used to continuously measure the
size of the micronized particles. The coupling of HME with PAT
tools is not limited to these two CM probes; it can involve addi-
tional PAT tools such as Raman or ultrasonic probes at diﬀerent
stages of the manufacturing process.
Oﬀ-line NIR spectra of IND, SCH, and the physical mixture
(PM) were measured to identify the characteristic vibrational
bands of these materials so that any new vibrational bands
formed during extrusion could be attributed to the cocrystals.
The second derivative NIR spectra of IND, SCH, and the PM in
the 4200−6300 cm−1 wavenumber region are shown in Figure 1S.
The characteristic vibrational bands of the PM fall between the two
component bands, and no shift can be detected, indicating no
interaction between the components. As shown in Figure 3 the
second derivative spectra of bulk components and the extruded
cocrystals show signiﬁcant diﬀerences due to band shifts.
The absorption band at 5022 cm−1 is attributed to the OH
stretching of the IND molecule. In the spectrum of the extruded
cocrystals, the band was shifted to 4988 cm−1, and it was
attributed to the stretching of OH groups.31 The band shift at
lower wavenumber is related to the H-bonding between the -OH
with the -NH group of SCH due to the formation of cocrystals
between IND and SCH.32,33 It can also be seen that the intensity
of the band at 4988 cm−1 is identical for the batches processed
between 155 and 165 °C, while it gets stronger for those
processed at 175 °C. The diﬀerence is not associated with the
quality of the cocrystals, but to the increase in the screw speed,
which has an eﬀect on the NIR recorded spectra. Previous studies
showed that the pressure and torque change in the extruder barrel or
the die explains the variation in the intensity of the NIR spectra.34
Figure 4. SEM images of HME processed cocrystals of (A) bulk IND, (B) bulk SCH, (C) 10 rpm/155 °C, (D) 30 rpm/165 °C, (E) 100 rpm/175 °C
(1.0 kg/h), and (F) 100 rpm/175 °C (1.5 kg/h).
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SEM micrographs (Figure 4) of bulk IND showed irregular-
shaped crystals with the particle size varying from 5−10 μm,
while the SCH coformer presented prismatic-shaped crystal
morphology with particle sizes varying from 50 to 70 μm.
The extruded cocrystals revealed cuboid shapes in the form of
agglomerates. An increase in the screw speed and the extrusion
Figure 5. Particle size analysis by using (A) sieve, and Parsum probe (free fall, D23 inductor) for the 30 rpm/165 °C “as made” cocrystals, (B) sieve, and
Parsum probe (D23 inductor) for the 100 rpm/175 °C “as made” cocrystals, (C) laser diﬀraction, and Parsum probe (D23 inductor) for the 100 rpm/
175 °C milled cocrystals.
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temperature, due to the scale-up requirements, did not have an
eﬀect on the morphology of the diﬀerent cocrystal batches.
In-line particle size measurements were carried out for all the
cocrystal batches during the scale-up optimization at two
diﬀerent stages and compared with oﬀ-line particle size analysis.
The cocrystal particle size was measured at the end of the
extrusion process for the “as made” batches and after milling
where the size was further reduced by using a cutter mill. In order
to optimize the process of in-line monitoring two parameters
were selected, named D23 in-line disperser and free fall. The D23
inductor incorporates a nozzle with an air supply, which disperses
and accelerates particles toward the measuring zone, while free
fall applies for particles with gravitational ﬂow. As it can be seen,
both settings of the particle probe are related to the expected
average particle velocity. The in-line particle size probes are
placed underneath the cutter mill, and the particle size distri-
bution is continuously recorded every 1 min until the end of the
process.
The in-line particle size analysis revealed that IND−SCH
cocrystals leave the extruder in the form of agglomerates when
the extrusion temperature exceeds 165 °C. The agglomerates
(which constituted ∼30% of the total particles), produced at an
Figure 6.DSC thermograms of (black trace) 10 rpm/155 °C, (blue trace) 30 rpm/165 °C, (purple trace) 100 rpm/175 °C (1.0 kg/h), and (red trace)
100 rpm/175 °C (1.5 kg/h) extruded cocrystals.
Figure 7. XRPD diﬀractorgrams of (brown trace) 10 rpm/155 °C, (blue trace) 30 rpm/165 °C, (red trace) 100 rpm/175 °C (1.0 kg/h), and
(black trace) 100 rpm/175 °C (1.5 kg/h) extruded cocrystals.
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extrusion temperature above 165 °C, displayed a particle size
between 1000 and 2000 μm, and thus further micronization was
required before capsule ﬁlling. For this reason a cutter mill was
employed at the end of the extrusion processing to reduce
the particle size of the cocrystals to the desired speciﬁcations
(a 250 μm mesh was used). As shown in Figure 5A the free fall
settings of the Parsum probe for the “as made” cocrystals dis-
played a similar particle size distribution in the range of
250−2000 μm with the oﬀ-line sieve analysis. However, the
use of the “free fall” setting did not detect smaller particle sizes
(<250 μm) due to the large agglomerates obtained at the end of
the extrusion process. The use of the D23 in-line disperser
provided a better determination of smaller particles, but an
increase in the volume (%) particles between 1000 and 2000 μm
was detected. According to Silva et al. (2013), this could be due
to the particle coincidence, where if, occasionally, two particles
cross at the same time through the measurement cell the probe
may not be able to diﬀerentiate the individual particles and regard
them as a single one.35 Nevertheless, the D23 inductor showed a
good correlation of the particle size distribution with sieve analysis
for the “as made” cocrystals at 175 °C/100 rpm (Figure 5B).
On the basis of the foregoing results, the in-line measurements
of the milled cocrystals (165 °C/100 rpm, 175 °C/100 rpm)
were conducted by using the D23 inductor and compared with
sieve analysis and laser diﬀraction. The particle size distributions
obtained (Figure 5C) were similar for both in-line and oﬀ-line
measurements. Overall, spatial ﬁlter velocimetry proved eﬃcient
for in-line particle size monitoring and an excellent PAT tool for
quality control. Tuning of the measurement parameters is a pre-
requisite for obtaining reliable results.
The synthesis and quality of cocrystals were further conﬁrmed
by DSC and XRPD. DSC was used to analyze extruded cocrystals
in comparison to bulk materials, and Figure 6 represents the
thermograms of successfully synthesized cocrystals after opti-
mization of the process parameters. The melting endotherms
appear sharp, similar to bulk IND, with melting points varying
Figure 8. (a) Dissolution proﬁles of bulk IND, IND−SCH bulk cocrystals (“as made” and milled), and formulated in soft gelatin capsules.
(b) Dissolution proﬁles of IND−SCH bulk cocrystals (“as made”) at various extrusion processing parameters (F2, F4, F8).
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from 182.5 to 183.3 °C. This is impressive as the melting peaks
of both small volume and scaled-up batches of cocrystals
(0.3−1.5 kg/h) lie in a very narrow temperature range suggesting
a highly reproducible process. The XRPD analyses of the bulk
components are shown in Figure 8 where IND showed
characteristic intensity peaks at 10.25, 11.67, 16.77, 17.02, 19.68,
21.87, 23.99, 26.61° 2θ. Intense peaks of bulk SCHwere identiﬁed
at 9.56, 15.91, 16.02, 17.23, 19.13, 25.14 2θ. The diﬀractogram of
the IND−SCH physical mixture presented XRPD peaks of lower
intensities that belonged to both IND and SCH.
However, the diﬀractograms of the extruded cocrystals showed
a unique XRPD pattern compared to their parent compounds,
which were identical to published data collected from the
Cambridge Crystallographic Data Centre (CCDS) (CCDS
REF: UFERED). All the unsuccessfully extruded cocrystals
presented the same XRPD patterns with two peaks at 10.21°
and 14.42° 2θ, respectively (Figure 2S). These are characteristic
peaks for IND and suggest the presence of unreacted drug due to
incomplete cocrystal formation. High purity cocrystals were
obtained with optimized process variables (Table 1) without any
traces of unreacted material, and typical peaks of IND−SCH
cocrystals were identiﬁed at 2θ values of 5.43, 10.89, 14.42, 21.22,
25.45, and 27.07°. The Rietveld analysis showed that the purity of
extruded cocrystal batches varied from 98.4−98.9% including the
scaled - up extrudates.
The dissolution rates of synthesized cocrystals were investi-
gated in phosphate buﬀer solution (pH 6.8) in comparison to
bulk IND. The data in Figure 8a show a signiﬁcant increase in the
dissolution rates of the cocrystals with 60−70% being dissolved
within the ﬁrst 60 min with respect to 30% of the bulk drug.32
A Kruskal−Wallis nonparametric analysis showed no signiﬁcant
diﬀerence of the dissolution rates for cocrystals formed at various
temperatures (155−175 °C) during the process scale-up. As
shown in Figure 8b the CBZ−SCH dissolution rates were almost
identical with 81−87% dissolved in 120 min. This is an important
observation showing that temperature has no impact on the
dissolution rates of the cocrystals. It is obvious that processing
parameters such as feed rate and screw speed do not inﬂuence the
dissolution behavior of the cocrystals either. However, it worth
mentioning that this observation is eﬀective only for the successful
scaled-up cocrystals batches, which present the similar crys-
tallinity, estimated by Rietveld analysis. In a previous study,
Moradiya36,37 et al. showed that extrusion temperatures aﬀect
the quality of cocrystals and subsequently the dissolution rates.
In contrast, the particle size of cocrystals can have an inﬂuence on
their dissolution proﬁles.38 As shown in Figure 8a cocrystals
subjected to processing by milling produced smaller particles
with increased amounts of ﬁne particles between 63 and 125 μm.
As a result the dissolution rate of cocrystals increased to 60%
within the ﬁrst 15 min and 70% in 30 min. Figure 8a also shows
the eﬀect of the soft gelatin capsules and the bulk excipients on
the rates of dissolution of the cocrystals. The ﬁlling of gelatin
capsules with cocrystals resulted in 20% less drug release in the
ﬁrst 10 min. The results showed that careful consideration of the
selected capsule ﬁllers is required as they also caused retardation
of IND release compared to capsules ﬁlled with pure cocrystals.
■ CONCLUSIONS
In conclusion the current study is a paradigm that continuous
manufacturing of pharmaceutical cocrystals with high throughput,
yield, and quality can be successfully achieved by using extrusion
processing coupled with PAT tools and downstream processing
equipment. CM was developed by using only six operational units
with small footprint for the production of cocrystals ﬁlled in
capsules. The implementation of a QbD approach led to process
optimization and helped to identify the process boundary.
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Additional Figures 
 
Figure S1. Image of a twin – screw Eurolab 16 extruder use for continuous cocrystallization 
processing. 
 
 
Figure S2. Image of the cutter mill used for cocrystal particle size reduction. 
  
 
Figure S3. Image of the Mini Cap capsule filler. 
 
 
Figure S4. Image of the Parsum probe used for in line particle size measurements. 
 
 
  
 
Figure S5. 2
nd
 derivative NIR spectra of bulk IND, SCH and their physical mixture. 
 
 
Figure 6S.  2
nd
 derivative NIR spectra of unsuccessfully processed cocrystals (F1, F3, F5). 
  
 
Figure 7S. DSC thermograms of bulk IND, SCH and their physical mixture. 
 
Figure S8. DSC thermograms of unsuccessfully processed cocrystals (F1, F3, F5) and their 
physical mixture. 
 
  
 
Figure S9. XRPD diffractograms of unsuccessfully processed cocrystals (F1, F3, F5) and their 
physical mixture. 
 
